Introduction
Graves' orbitopathy is an auto-immune inflammatory disorder of the orbit that occurs in 25-80% of patients with autoimmune thyroidopathy. This disorder is characterized by inflammation, congestion, hypertrophia, and fibrosis of the extra-ocular muscles. [1] [2] [3] [4] Because patients with Graves' orbitopathy must be followed and treated on the basis of disease activity, several different classification systems based on the clinical assessment have been developed. 4, 5 The evaluation of Graves' orbitopathy activity is important for predicting medical treatment results because treatment is more effective in the active phase. 1.2 Different scores have been developed to detect activity of the disease, such as the clinical activity score (CAS), the European Group of Graves' Orbitopathy (EUGOGO) classifications and the vision, inflammation, strabismus, and appearance (VISA). 5 The CAS is based on four classical signs of inflammation (pain, redness, swelling, and impaired function), and consists of 10 equally weighted items. The total CAS may range from 0-10. The higher the CAS, the greater is the response to immunosuppression. The CAS in Graves' orbitopathy is correlated with immunosuppressant treatment response 6 and laboratory tests such as thyroid-stimulating hormone. 7 Different imaging modalities such as computed tomography, color Duplex ultrasound and routine magnetic resonance imaging are used for assessment of patients with Graves' orbitopathy. [8] [9] [10] Routine and contrast magnetic resonance imaging are used to differentiate active from inactive Graves' orbitopathy based upon signal intensity value on short Tau inversion recovery images (STIR) and degree of contrast enhancement of the extra-ocular muscles, but there is overlap in signal intensity value and degree of enhancement. [11] [12] [13] [14] Color Duplex ultrasound can differentiate congestive from fibrotic Graves' orbitopathy based upon the flow of the superior ophthalmic vein, but there is overlap in the resistive index of the superior ophthalmic vein and the ultrasound is an operatordependent technique. 15, 16 Computed tomography and isotope study may help in this differentiation, but they are associated with radiation exposure and overlap in cross-sectional areas of extra-ocular muscles at computed tomography and degree of isotope uptake at isotope study. [17] [18] [19] Diffusion-weighted magnetic resonance imaging can provide better characterization of tissues and their physiologic processes because it reflects the random motion of water protons, which is disturbed by intracellular organelles and macromolecules located in the tissues. Thus, the apparent diffusion coefficient (ADC) values of the tissues vary according to the pathological nature and cellularity of the tissues. [20] [21] [22] Diffusion-weighted magnetic resonance imaging is used for characterization of orbital 23 and thyroid lesions 24 and thyroid orbitopathy. [25] [26] [27] The aim of this work is to determine the performance of ADC in the detection of involvement of the medial and lateral rectus muscles in patients with Graves' orbitopathy.
Methods and materials Patients
The Institutional Ethics Committee approved the protocol of the study and informed consent was given by all patients. A prospective study was performed on 40 patients with Graves' orbitopathy. We excluded seven patients from the study because of distortion of the extra-ocular muscles with poor image quality that limited analysis of the muscles. The final group of included patients in this study were 33 consecutive patients (16 males and 17 females aged from 18-55 years with mean age of 36 AE 12.2 years) with Graves' orbitopathy and 18 age-and sex-matched volunteers (eight males and 10 females with mean age of 31.5 AE 11.3 years). The inclusion criteria were patients with Graves' orbitopathy according to the diagnostic criteria for Graves' ophthalmopathy. 28 The control group consisted of age-and sex-matched healthy volunteers with negative results of any thyroid abnormality. Of the patients, 10 were without treatment and other patients were treated with 1-methyl-2-mercaptoimidazole (10), iodine (seven), steroids (four) and radiation therapy (two). The magnetic resonance imaging of the orbit was done for patients and volunteers and the clinical activity score (CAS) was obtained for patients before treatment in 10 patients and after therapy in other patients. The CAS 5 was calculated by one endocrinologist with 10 years experience. A score of three or more on CAS is classified as active Graves' orbitopathy. The time between magnetic resonance imaging and CAS score was 3-7 days. Patients were subdivided into active orbitopathy in 17 patients and inactive orbitopathy in 16 patients.
Magnetic resonance imaging
Magnetic resonance imaging was performed at 1.5 tesla magnetic resonance machine (Symphony; Siemens Medical Systems, Erlangen, Germany) using a head circular polarization surface coil. All patients underwent T1-weighted images (repetition time/echo time (RT/ ET) of 800/15 ms) and T2-weighted fast spin echo images (RT/ET of 4500/80 ms) with a section thickness of 3 mm, an inter-slice gap of 1 mm, a field of view of 20 Â 25 cm and an acquisition matrix of 256 Â 256. The images were obtained in the axial plane. Diffusionweighted magnetic resonance images were obtained using a multi-slice echo-planar imaging sequence in the axial plane. Imaging parameters were; RT/ET of 10.000/108 ms, field of view of 20 Â 25 cm, an acquisition matrix of 256 Â 128 and section thickness of 3 mm with an interslice gap of 1 mm. Diffusion probing gradients were applied in the three orthogonal directions (x, y, and z) with the same strength. Diffusion-weighted magnetic resonance images were acquired with diffusion weighted factor, factor b of 0, 500 and 1000 s/ mm 2 and ADC maps were generated. The data acquisition time for the diffusion-weighted images was one minute.
Image analysis
Image analysis was performed by one radiologist (AAR) expert in head and neck imaging with 22 years of experience. A quantitative analysis of the ADC was made. A region of interest using the electronic cursor was done in the mid part of the medial and lateral extra-ocular rectus muscles away from adjacent fat planes (Figure 1 ).
Statistical analysis
The statistical analysis of data was done using Excel and SPSS (Statistical Package for Social Science version 20). The description of data was done in the form of mean and standard deviation (SD). The Kolmogorov Smirnov (K-S) test was done for diagnosis normality of data distribution. All data were revealed to be parametric with normal distribution. The analysis of data was done to test statistical significant difference. To compare between two groups the student t-test was used. To compare between more than two groups a one-way analysis of variance (ANOVA) test was used. The receiver operating characteristic curve was done to determine the cut-off point with highest accuracy that used to differentiate patients with Graves' orbitopathy from volunteers. The p value was considered significant if 0.05 at confidence interval of 95%.
Results
The CAS of patients with active disease (n ¼ 17) was 5 AE 0.98 [4] [5] [6] [7] and for patients with inactive disease (n ¼ 16) was 1.75 AE 0.24 with significant difference in between (p ¼ 0.001). There was a significant difference in the disease duration (p ¼ 0.001) between active (1.1 AE 0.21 years) and inactive disease (2.41 AE 0.78 years). Table 1 shows the ADC value of the medial and lateral rectus muscles in patients with Graves' orbitopathy and volunteers.
The medial rectus muscle was more affected than the lateral rectus muscle. The mean ADC value of the medial and lateral rectus muscles was 1.81 AE 0.19 and 1.72 AE 0.07 Â 10 À3 mm 2 /s in patients with Graves' orbitopathy ( Figure  1 ) and 1.59 AE 0.06 and 1.51 AE 0.06 Â 10 À3 mm 2 /s in volunteers (Figure 2) , respectively. There was a statistically significant difference in the ADC values of the medial and lateral rectus muscles between patients with Graves' orbitopathy and volunteers (p ¼ 0.001). When an ADC value of 1.69 Â 10 À3 mm 2 /s of the medial rectus muscle was used as a threshold value for differentiating Graves' orbitopathy from volunteers, the best result was obtained with area under the curve (AUC) of 0.89 AE 0.09, 95% CI 0.732-0.904, accuracy of 86%, sensitivity of 97% and specificity of 97% (Figure 3 ).
Discussion
In this study, the ADC values of the medial and lateral rectus muscles of patients with Graves' orbitopathy are significantly different from those of volunteers (p ¼ 0.001). This may be attributed to infiltration of the medial and lateral extra-ocular rectus muscles with hyaluronic acid formed by fibroblasts. Hyaluronic acid is hydrophilic glycosaminoglycan that retains water and becomes edematous. [1] [2] [3] [4] This changes results in increasing the diffusion space of the water protons in the extracellular and intracellular dimensions with a resultant increase in the ADC value. [22] [23] [24] One study reported that there is significant difference in the ADC value of the extra-ocular muscles in patients with Graves' orbitopathy versus controls.
The ADC values of all the extra-ocular muscles are higher in patients. There is a significant difference in the ADC values between the uninvolved muscles on conventional magnetic resonance imaging and controls for the medial rectus, superior rectus, and lateral rectus muscles. The ADC values of medial, lateral, and superior rectus muscles are increased. 25 Another study added that the ADCs of normally functioning extraocular muscles of patients with Graves' orbitopathy are higher than those of healthy controls. 26 Another study added that in the medial rectus, fractional anisotropy was significantly lower in patients (p ¼ 0.001) and negatively correlated with muscle thickness (r ¼ À0.604, p ¼ 0.001). Radial diffusivity was significantly higher in patients (p ¼ 0.010) and correlated with muscle thickness (r ¼ 0.349, p ¼ 0.027). In the lateral rectus muscles, the diffusion tensor imaging values did not differ between patients and controls. 27 There are a few limitations of this study. First, this study is limited by the small number of patients in the active and inactive forms of the disease during the course of treatment and this may alter the ADC values; further studies upon large number of patients before and during the course of treatment would help in differentiation between active and inactive disease forms. Second, analysis of diffusion-weighted magnetic resonance imaging was done with an ROI with potential to measure part of adjacent fat. Normal volunteers have smaller muscles and Graves' patients have larger muscles which may impact on the size of the ROI and the number of voxels included in the ADC and many patients with Graves' orbitopathy do not have all extraocular muscles enlarged and may not have both lateral and medial rectus involved. Future studies with application of advanced post-processing such as bi-exponential, non-Gaussian (diffusion kurtosis) modeling or K-means clustering algorithms will improve the results. 29, 30 Third, this study applied diffusion-weighted magnetic resonance imaging, further studies with application of multi-parametric imaging of diffusionweighted magnetic resonance imaging with diffusion tensor magnetic resonance imaging, dynamic contrast magnetic resonance imaging and proton magnetic resonance spectroscopy at higher 3 tesla scanner of the extra-ocular muscles may improve the results. [31] [32] [33] [34] [35] [36] 
Conclusion
We concluded that ADC of the medial rectus muscle can be used for diagnosis of Graves' orbitopathy.
